Saudi Arabia Sleep Apnea Devices Market, By Type (Therapeutic Devices, Diagnostic Devices), By Indication (Obstructive Sleep Apnea, Central Sleep Apnea), By End User (Hospitals & Clinics, Homecare), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

Saudi Arabia Sleep Apnea Devices market was valued at USD 4.35 Billion in 2024 and is expected to reach USD 5.94 Billion by 2030 with a CAGR of 5.28%. The Saudi Arabia Sleep Apnea Devices Market has experienced consistent growth, primarily driven by increased awareness of sleep disorders, notably Obstructive Sleep Apnea (OSA), and a corresponding rise in demand for both diagnostic and therapeutic solutions. The market spans a variety of products tailored to address sleep-related breathing disorders, including polysomnography (PSG) devices, home sleep apnea testing (HSAT) kits, and therapeutic devices such as CPAP (Continuous Positive Airway Pressure) machines, BiPAP (Bilevel Positive Airway Pressure) devices, and oral appliances.

The Saudi Arabia Sleep Apnea Devices Market is set for sustained expansion. The growing awareness, coupled with increasing diagnosis rates and continuous technological innovations in sleep apnea treatments, will further propel the adoption of advanced devices. Moreover, government initiatives particularly those outlined in Vision 2030 focused on enhancing healthcare access and improving chronic disease management, are expected to play a pivotal role in supporting the market's continued growth.

Key Market Drivers

Rising Prevalence of Sleep Disorders and Obstructive Sleep Apnea (OSA)

The increasing prevalence of sleep disorders, particularly Obstructive Sleep Apnea (OSA), plays a pivotal role in propelling the growth of the Saudi Arabia Sleep Apnea Devices Market. Research indicates that Obstructive Sleep Apnea (OSA) is a growing public health concern in Saudi Arabia, with recent prevalence estimates suggesting that approximately 8.8% of the adult population may be affected. However, available data does not provide a definitive breakdown of OSA cases as a proportion of all diagnosed sleep apnea types in the Kingdom. As such, while OSA is widely recognized as the most clinically encountered form of sleep apnea, there is currently insufficient epidemiological evidence to support claims that it accounts for 80–90% of all sleep apnea diagnoses in the Saudi population. Saudi Arabia exhibits some of the highest rates of obesity, type 2 diabetes, and cardiovascular disease in the Middle East all of which are strongly correlated with OSA. Public health data reveals that obesity impacts more than 35% of Saudi Arabia’s adult population, underscoring its status as a critical health challenge. A systematic review examining the national obesity burden further reported that prevalence rates across different studies and regions ranged between 20% and 39%, reflecting significant variability influenced by demographic, geographic, and lifestyle factors. Excess body weight, particularly in the upper body and neck region, is a major contributor to airway obstruction during sleep, directly increasing OSA risk. As the prevalence of these underlying health conditions grows, so does the population of individuals at risk of sleep apnea. This, in turn, fuels demand for diagnostic tools such as polysomnography (PSG) systems, home sleep test kits, and therapeutic devices including CPAP and BiPAP machines.

Historically, sleep apnea has been significantly underdiagnosed in Saudi Arabia, largely due to limited public awareness and cultural stigmas around seeking treatment for sleep-related issues. However, in recent years, increased public health campaigns and growing media attention have brought sleep disorders into the mainstream healthcare conversation. More individuals are now recognizing the symptoms of OSA such as loud snoring, daytime fatigue, and poor concentration and are actively seeking medical consultation. As a result, sleep clinics and hospitals are experiencing increased patient volumes for sleep evaluations, boosting demand for both diagnostic equipment and long-term therapeutic solutions.

With the growing awareness of sleep disorders, there is a noticeable expansion in sleep medicine infrastructure across the kingdom. New sleep centers and hospital-based sleep labs are being established, particularly in major cities such as Riyadh, Jeddah, and Dammam. These facilities are equipped with advanced diagnostic and therapeutic technologies, creating a favorable environment for market expansion. According to a national survey, the number of sleep medicine specialists in Saudi Arabia, as defined by the Saudi Commission for Health Specialties (SCFHS) (requiring a minimum of six months of full-time fellowship training in sleep medicine), stands at just 37 professionals. This equates to a ratio of 0.012 specialists per 100,000 people, which is significantly below the benchmarks seen in developed countries, highlighting a critical gap in specialized sleep care services within the Kingdom. This expansion opens new revenue streams for medical device manufacturers and distributors, who are now catering not only to end-users but also to institutional buyers in the clinical setting. OSA is a chronic condition that requires ongoing management. As more cases are diagnosed, the market sees a corresponding surge in demand for long-term treatment devices, primarily CPAP machines, which are considered the gold standard in OSA therapy. Additionally, patient demand is shifting toward portable, comfortable, and digitally integrated devices that can support consistent therapy both at home and while traveling. Manufacturers that offer such features like automated pressure adjustment, wireless data transmission, and remote patient monitoring are experiencing a competitive edge in capturing this growing segment.

Growing Geriatric and At-Risk Population

The expansion of the geriatric population, along with a sharp rise in individuals classified as medically at-risk, is significantly influencing the growth trajectory of the Saudi Arabia Sleep Apnea Devices Market. This demographic evolution is creating sustained demand for both diagnostic and therapeutic devices, establishing a stable and expanding customer base for market participants. Saudi Arabia is witnessing a substantial increase in its elderly population, with projections forecasting a five-fold surge in individuals aged 60 and above between 2020 and 2050. This demographic shift is primarily driven by advancements in healthcare and living standards, which have contributed to extended life expectancies and a reduction in mortality rates. By 2050, it is projected that over 23% of the population will be aged 60 or older, presenting both challenges and opportunities for the country, particularly in terms of healthcare infrastructure, social services, and market demand for age-related products and services. Advancing age is one of the most well-documented risk factors for Obstructive Sleep Apnea (OSA) and other sleep-related breathing disorders. As individuals age, the muscles in the throat tend to relax, and structural changes in the airway increase the likelihood of collapse during sleep. Moreover, aging is associated with a higher prevalence of comorbidities such as hypertension, atrial fibrillation, stroke, and neurodegenerative disorders that are strongly linked to sleep-disordered breathing. Saudi Arabia, like many developed and rapidly developing nations, is experiencing a demographic shift marked by a rising percentage of citizens aged 60 years and above. According to national statistics, the geriatric population is expected to double within the next two decades, thereby increasing the prevalence of sleep-related disorders within this age group.

Older adults and patients with chronic health conditions are typically more engaged with the healthcare system. They undergo more frequent clinical evaluations, are more likely to be referred to specialists, and are more open to medical interventions aimed at improving quality of life. As a result, there is greater clinical attention to the diagnosis and treatment of sleep apnea within these groups, directly increasing demand for polysomnography devices, CPAP therapy units, auto-adjusting PAP systems, and oxygen therapy devices. Additionally, primary care providers and geriatricians are becoming increasingly proactive in screening elderly patients for sleep-related symptoms such as fatigue, insomnia, and cognitive decline symptoms often overlooked or misattributed in this population. Apart from age, Saudi Arabia is witnessing a rise in chronic non-communicable diseases such as diabetes, obesity, cardiovascular disease, and respiratory disorders many of which are prevalent in middle-aged and older adults. These conditions are not only risk factors for OSA but also exacerbate its impact, making timely diagnosis and management critical. This medical reality is creating a captive and recurring market for sleep apnea treatment products, especially among patients who require long-term or lifelong therapy.

Download Free Sample Report

Key Market Challenges

Low Awareness and Underdiagnosis of Sleep Apnea

Despite increasing public health initiatives, a lack of awareness about sleep apnea remains one of the most significant barriers to market expansion in Saudi Arabia. Many individuals suffering from Obstructive Sleep Apnea (OSA) are unaware of their condition, often mistaking symptoms like fatigue, loud snoring, and disrupted sleep for unrelated health issues or lifestyle factors.

Compounding this issue is a low level of clinical diagnosis, particularly in rural and semi-urban areas. Limited knowledge among general practitioners and primary care providers regarding sleep medicine often leads to missed or delayed referrals to sleep specialists. This results in a large pool of undiagnosed patients who do not enter the treatment pipeline, thereby directly suppressing demand for diagnostic equipment and therapeutic devices such as CPAP machines.

Limited Availability of Specialized Sleep Centers and Trained Personnel

The Saudi healthcare infrastructure, while rapidly advancing, still lacks sufficient specialized sleep laboratories and trained sleep medicine professionals. Most sleep labs are concentrated in major urban centers like Riyadh and Jeddah, leaving large parts of the country underserved.

This geographical imbalance creates accessibility challenges for patients in remote or underserved areas, who often need to travel long distances for sleep testing or follow-up care. Moreover, there is a noticeable shortage of certified sleep technicians, respiratory therapists, and trained physicians, which slows down patient evaluation and treatment initiation. This infrastructure gap poses a significant obstacle to scaling up the diagnosis and long-term management of sleep apnea on a national level.

Key Market Trends

Integration of Digital Health and Remote Patient Monitoring

A defining trend in the Saudi sleep apnea market is the integration of digital health technologies, particularly remote monitoring platforms and cloud-based data analytics. Devices such as smart CPAP machines now offer real-time data transmission, mobile app connectivity, and automated compliance tracking, enabling physicians to monitor patient adherence without requiring frequent in-person visits.

This shift is especially relevant in Saudi Arabia’s growing urban and tech-savvy population and aligns with the national push toward e-health under Vision 2030. Remote monitoring not only improves clinical outcomes by promoting adherence but also enhances the scalability of treatment services across the country. This trend is expected to accelerate adoption, especially in homecare settings, while enabling providers to deliver personalized, data-driven therapy.

Emergence of Local Manufacturing and Regional Assembly

Another important trend is the gradual emergence of local manufacturing and assembly partnerships within Saudi Arabia and the wider GCC region. In alignment with the Kingdom’s localization goals and economic diversification strategy, several international medical device firms are exploring or establishing local production units, joint ventures, or distribution alliances.

This movement aims to reduce supply chain dependency, lower import costs, and accelerate product availability in the local market. Over time, it will lead to improved customization of devices to suit regional needs and potentially introduce more competitively priced offerings, especially for entry-level or home-use segments. It also presents an opportunity for Saudi Arabia to position itself as a regional hub for sleep and respiratory care technology.

Segmental Insights

Type Insights

Based on the category of Type, the Therapeutic Devices segment emerged as the fastest growing segment in the Saudi Arabia Sleep Apnea Devices Market in 2024. This is primarily due to the chronic nature of Obstructive Sleep Apnea (OSA), which requires continuous, long-term management rather than one-time diagnosis. Once a patient is diagnosed, the demand shifts toward treatment continuity, positioning therapeutic devices as the core revenue generator. Among therapeutic devices, Continuous Positive Airway Pressure (CPAP) machines represent the gold standard in OSA therapy and account for a substantial portion of overall market value. Other sub-categories include BiPAP machines, AutoPAP devices, humidifiers, and oral appliances all of which serve diverse patient profiles and severity levels.

Therapeutic devices are not only dominant they are also emerging as the fastest-growing segment in the Saudi market. Several factors contribute to this accelerated growth: Rising diagnosis rates driven by increasing public awareness. Growing patient compliance due to the availability of portable, user-friendly, and smart-enabled CPAP devices. Expansion of home healthcare services, which favor therapeutic solutions for convenience and long-term use. The recurring revenue model from accessories and consumables such as masks, tubing, and filters. Advancements in remote monitoring and Bluetooth-enabled therapy management have improved adherence and made these devices more appealing to both patients and clinicians, thereby accelerating adoption. These factors are expected to drive the growth of this segment.

Indication Insights

Based on the category of Indication, the Obstructive Sleep Apnea segment emerged as the dominating segment Saudi Arabia Sleep Apnea Devices Market in 2024. The high prevalence of OSA is attributed to several interrelated factors such as: High obesity rates in the population (a major risk factor for OSA). Increased incidence of hypertension, diabetes, and metabolic syndrome. Anatomical predispositions such as narrow upper airways or enlarged tonsils, particularly in males. These clinical realities have made OSA the primary focus of both diagnosis and treatment protocols across public and private healthcare institutions in the Kingdom.

Due to the chronic and progressive nature of OSA, there is a consistent and high demand for therapeutic interventions, particularly: CPAP (Continuous Positive Airway Pressure) devices, Auto-CPAP and BiPAP machines, Oral appliances and positional therapy devices. Since OSA requires long-term management, the recurring nature of treatment and device dependency positions this indication segment as the primary revenue generator in the overall sleep apnea market. Government-led initiatives under Saudi Vision 2030 emphasize the importance of addressing lifestyle-related chronic diseases, including OSA. Medical institutions are enhancing screening programs for OSA as part of broader chronic disease management, further reinforcing this segment’s dominance. Increased public awareness campaigns about snoring, excessive daytime sleepiness, and sleep quality have led to higher rates of self-reporting and diagnosis of OSA, reinforcing demand for both diagnostic and therapeutic devices.

Download Free Sample Report

Regional Insights

Western Region, which includes major cities such as Jeddah and Mecca, stands out as the largest market for sleep apnea devices in Saudi Arabia. Jeddah, a commercial hub, and Mecca, a major pilgrimage site, are home to a dense and diverse urban population. This region boasts advanced healthcare facilities, specialized sleep centers, and medical professionals, contributing to higher awareness and diagnosis rates of sleep apnea. The Western region has high rates of obesity, diabetes, and hypertension, which are strongly correlated with Obstructive Sleep Apnea (OSA). Consequently, there is a high demand for both diagnostic and therapeutic devices, particularly CPAP and BiPAP machines. The presence of Mecca as a global religious destination further boosts demand for healthcare services, including sleep studies and apnea treatments, as many international pilgrims and visitors seek medical assistance during their stay. The region’s proximity to key importation hubs in Jeddah facilitates the steady supply of sleep apnea devices, contributing to its market dominance.

Recent Developments

• In January 2023- Vivos Therapeutics received FDA clearance for its mouthpiece designed to treat Obstructive Sleep Apnea (OSA), now classified as a Class II medical device. Previously, this device was designated as a Class I device for use as a palatal expander. With the new FDA approval, the device now carries an updated indication for OSA treatment, reflecting its evolving role in non-invasive therapeutic solutions for individuals suffering from this condition.

Key Market Players

• ResMed
• Philips
• Invacare Corporation
• Itamar Medical Inc.
• Nihon Kohden Middle East FZE

Report Scope:

In this report, the Saudi Arabia Sleep Apnea Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Saudi Arabia Sleep Apnea Devices Market, By Type:

o   Therapeutic Devices

o   Diagnostic Devices

• Saudi Arabia Sleep Apnea Devices Market, By Indication:

o   Obstructive Sleep Apnea

o   Central Sleep Apnea

• Saudi Arabia Sleep Apnea Devices Market, By End User:

o   Hospitals & Clinics

o   Homecare

• Saudi Arabia Sleep Apnea Devices Market, By Region:

o   Western

o   Central

o   Southern

o   Eastern

o   Northern

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Saudi Arabia Sleep Apnea Devices Market.

Available Customizations:

 Saudi Arabia Sleep Apnea Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).